Ghoshal Kaushik's Form 4 filing
Resmed Inc (RMD) · filed Aug 13, 2024
- Accession no.
- 0001127602-24-022064
- Filed
- Aug 13, 2024
- Trade date
- Aug 12, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.17M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ghoshal KaushikCIK 0001881922 | Officer (President, SaaS Business) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseAcquired | +2,086 | $95.80 | +$199,838.8 | 15,118 | Direct | |
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseAcquired | +6,877 | $95.80 | +$658,816.6 | 21,995 | Direct | |
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseAcquired | +1,037 | $101.64 | +$105,400.68 | 23,032 | Direct | |
| Aug 12, 2024 | ResMed Common Stock | SSaleDisposed | −10,000 | $216.60 | −$2,166,000 | 13,032 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseDisposed | −2,086 | $0.00 | $0 | 0 | Direct | |
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseDisposed | −6,877 | $0.00 | $0 | 0 | Direct | |
| Aug 12, 2024 | ResMed Common Stock | MOption exerciseDisposed | −1,037 | $0.00 | $0 | 9,260 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.